Posts

Posted on

Bank7 Corp. Announces Fourth Quarter and Full Year 2020 Earnings Conference Call

PR Newswire

OKLAHOMA CITY, Jan. 12, 2021 /PRNewswire/ — Bank7 Corp. (NASDAQ: BSVN), the parent company of Oklahoma City-based Bank7, announces that its financial results for the fourth quarter and full year ending on December 31, 2020 will be released before the market opens on Friday, January 29, 2021 and at 10:00 a.m. central standard time that same day, the company will hold a conference call to discuss the financial results with investors. To participate in the call, dial 1-888-348-6421, or access it live over the Internet at https://www.webcaster4.com/Webcast/Page/2179/39520.

For those not able to participate in the live call, an archive of the webcast will be available at https://www.webcaster4.com/Webcast/Page/2179/39520 shortly after the call for 1 year.

About Bank7 Corp.

Bank7 Corp. is a bank holding company headquartered in Oklahoma City, Oklahoma. Through our wholly-owned subsidiary, Bank7, we operate nine locations in Oklahoma, the Dallas/Fort Worth, Texas metropolitan area and Kansas. We are focused on serving business owners and entrepreneurs by delivering fast, consistent and well-designed loan and deposit products to meet their financing needs. We intend to grow organically by selectively opening additional branches in our target markets and we will also pursue strategic acquisitions.

For more information about Bank7 and its products, visit www.bank7.com.

Contact: 
Tom Travis
Bank7
1039 N.W. 63rd St.
Oklahoma City, OK. 73116
Ph: 405-810-8600 / [email protected]

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/bank7-corp-announces-fourth-quarter-and-full-year-2020-earnings-conference-call-301203286.html

SOURCE Bank7 Corp.

Posted on

CIT Provides $42.5 Million in Financing for St. Louis Apartment Project

PR Newswire

NEW YORK, Jan. 12, 2021 /PRNewswire/ — CIT Group Inc. (NYSE: CIT) today announced that its Real Estate Finance business provided $42.5 million in financing for the construction of the new Terra At the Grove Apartment project in St. Louis, Missouri.

The four-story structure, to be built by St. Louis-based developer Green Street, is the first project in St. Louis to pursue FitWell Certification and is designed as a mixed-use project that will feature more than 300 residential units as well as ground-floor retail space and associated parking. Planned amenities include a large courtyard, outdoor pool, walking and running paths, business center, club and movie rooms and more.

“Our project’s central location near transportation corridors, entertainment venues, major employers and educational opportunities in the downtown St. Louis area makes it a highly attractive site for residential development,” said Phil Hulse, CEO and founder of Green Street. “We found CIT’s expertise and agility to be valuable assets as we worked to arrange this financing.”

“We are pleased to again support financing for Green Street as it continues its development of successful commercial real estate projects,” said Chris Niederpruem, managing director and group head for CIT’s Real Estate Finance business. “Having worked with Green Street before, we have come to respect their professionalism and skill in commercial real estate development and look forward to the successful completion of their latest project.”

CIT’s Real Estate Finance business, part of the Commercial Finance division, originates and underwrites senior secured real estate transactions. With deep market expertise, underwriting experience and industry relationships, the group provides financing for single properties, property portfolios and loan portfolios.

About CIT
CIT is a leading national bank focused on empowering businesses and personal savers with the financial agility to navigate their goals. CIT Group Inc. (NYSE: CIT) is a financial holding company with over a century of experience and operates a principal bank subsidiary, CIT Bank, N.A. (Member FDIC, Equal Housing Lender). The company’s commercial banking segment includes commercial financing, community association banking, middle market banking, equipment and vendor financing, factoring, railcar financing, treasury and payments services, and capital markets and asset management. CIT’s consumer banking segment includes a national direct bank and regional branch network. Discover more at cit.com/about.


MEDIA RELATIONS: 

John M. Moran

212-461-5507
[email protected]

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/cit-provides-42-5-million-in-financing-for-st-louis-apartment-project-301205506.html

SOURCE CIT Group Inc.

Posted on

Johnson Controls Customers Prioritize New Integrated Technologies for Healthy Buildings; Solutions Must Deliver for Healthy People, Healthy Places and a Healthy Planet

– Building decision makers are prioritizing the three mission critical focus areas of a Healthy Building: People, Places and Planet – according to independent studies of 800+ decision makers

– Delivering on all three areas traditionally represented a complex set of conflicting priorities

– Johnson Controls OpenBlue Healthy Buildings integrated technology solutions breaks the traditional conflict of cost versus sustainability and delivers critical outcomes for healthy, smart places and experiences

PR Newswire

CORK, Ireland, Jan. 12, 2021 /PRNewswire/ — Johnson Controls (NYSE: JCI), the global leader for smart, healthy and sustainable buildings, today announced results of independent surveys of 800+ building decision makers showing a clear shift to increased investment in healthy building trends and technologies.

“At the center of a vision for a healthy world must be healthy buildings to serve People, Places and Planet”

“At the center of a vision for a healthy world must be healthy buildings, and that means delivering on the most critical elements to serve People, Places and Planet,” said George Oliver, CEO of Johnson Controls. “Our OpenBlue technologies reinvent the building landscape, creating dynamic smart facilities that help businesses meet their sustainability commitments, while delivering healthy places, enriched experiences and cost savings. Johnson Controls leads the industry in translating new building technology capabilities into game-changing solutions that deliver on our focus of People, Places and Planet.”

As the only leader in the category with 135 years of experience, Johnson Controls is ideally positioned with technologies and solutions that accelerate the reinvention of healthy buildings. The surveys confirmed the need is greater than ever, with 90 percent of responding firms having dedicated resources to healthy buildings initiatives.

“Building owners are struggling to balance urgent and conflicting priorities between employee health and wellness with critically needed cost savings, increased revenue and sustainability targets,” said Michael Ellis, executive vice president and chief customer & digital officer at Johnson Controls. “Johnson Controls is best positioned to help businesses meet those sustainability commitments while delivering on our customers’ return on investment,” Ellis said.

The 2020 pandemic showed that few customers were able to reduce building operating costs despite lower occupancy, highlighting the need for technologies to deliver flexibility.

“Energy use should be dramatically lower when occupancy is low, but surprisingly less than one in ten building operators were able to reduce energy use more than 20 percent,” Ellis said. “At a time when companies are aggressively pursuing energy and cost savings, customers need and want solutions that help them do better, while increasing the health profile of those buildings. Johnson Controls OpenBlue technologies deliver a unique, game-changing capability to solve for healthy places, while simultaneously serving sustainability goals.”

The survey of facilities operators showed a range of specific investment priorities to meet goals for Healthy People, Healthy Places and a Healthy Planet:

Healthy People
Businesses are increasingly committed to employee health and wellness as a driver of high performing teams. The studies show an increase in investments by organizations toward wellness, clean air and peace of mind. 80 percent of respondents stated that protecting the health and safety of building occupants during the COVID pandemic and afterward is very or extremely important.

New factors are being included in this mix such as temperature control, disinfection, ventilation and air filtration which all require well maintained systems and equipment, enhanced through intelligent sensors and control software. The realities of the COVID pandemic have increased the potential benefit of these technologies and for contactless access and contact tracing. These capabilities can help increase overall building security through enhanced tracking of building guest and occupant access, flow and location, while maintaining trust. Johnson Controls delivers solutions for all of these needs and in support of broader wellness for people in shared spaces.

Healthy Places
Finding cost savings and making fast and informed decisions, supported by data, is a critical part of facility operations. In the Johnson Controls independent studies, 80 percent of facility executives stated that increasing flexibility to quickly respond to emergencies is a top driver for investment in technologies such as flexible facility monitoring and healthy air strategies.

The spaces in which people work, shop, entertain and live become more inviting, more efficient and less expensive to operate over time. Space optimization, capital planning and increasing the uptime and lifetime of assets all support operational performance and lead to cost savings & increased revenue opportunities for building operators. Johnson Controls OpenBlue, a complete suite of connected solutions and services, leverages digital integration to optimize the performance of buildings and assets.

Healthy Planet
Improvements in energy efficiency, renewable energy and smart building technology are becoming more critical each year. In the studies, 76 percent of facility executives stated that energy cost savings are a top driver for investment. These investments also influence corporate sustainability rankings, an important metric for attracting and retaining investors, employees and customers.

Buildings are responsible for about 40 percent of the planet’s total energy consumption and 36 percent of greenhouse gas emissions from energy use. But only 1 percent of buildings undergo energy efficient renovation every year. Effective action is crucial in aligning to increased regulation, decreasing energy consumption and increasing sustainability. For the health of the planet, the studies revealed that 57 percent of organizations plan to achieve net zero carbon or positive energy status in at least one facility in the next ten years.

Through ongoing efforts to create more healthy buildings, Johnson Controls has implemented more than 3,000 energy-savings performance contracting projects in North America alone. The result has been reductions of more than 29 million metric tons of carbon emissions from customer facilities and savings of $6B in energy and operating costs driven by a comprehensive suite of product and technology solutions. In fiscal year 2019 almost half of Johnson Controls revenue came from products and services that reduce energy use and improve sustainability. Johnson Controls helps building owners and occupants make efficient, productive decisions in support of healthy people, healthy places and a healthy planet.

To learn more, visit: https://www.johnsoncontrols.com/openblue/openblue-healthybuildings

To download summaries of the studies, please visit: https://www.johnsoncontrols.com/insights/2021/featured-story/healthy-buildings-pulse-study

About Johnson Controls:
At Johnson Controls, we transform the environments where people live, work, learn and play. From optimizing building performance to improving safety and enhancing comfort, we drive the outcomes that matter most. We deliver our promise in industries such as healthcare, education, data centers and manufacturing. With a global team of 100,000 experts in more than 150 countries and over 130 years of innovation, we are the power behind our customers’ mission. Our leading portfolio of building technology and solutions includes some of the most trusted names in the industry, such as Tyco®, YORK®, Metasys®, Ruskin®, Titus®, Frick®, Penn®, Sabroe®, Simplex®, Ansul® and Grinnell®. For more information, visit www.johnsoncontrols.com or follow us @johnsoncontrols on Twitter.


INVESTOR CONTACTS:


MEDIA CONTACTS:

Antonella Franzen

Chaz Bickers

Direct: 609.720.4665

Direct: 224.505.9290

Email: [email protected]

Email: [email protected] 

 

Ryan Edelman

 

Michael Isaac

Direct: 609.720.4545 

Direct: +41 52 6330374

Email: [email protected]  

Email: [email protected]

 

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/johnson-controls-customers-prioritize-new-integrated-technologies-for-healthy-buildings-solutions-must-deliver-for-healthy-people-healthy-places-and-a-healthy-planet-301206169.html

SOURCE Johnson Controls International plc

Posted on

Zynex Announces 117% Year over Year Order Growth and Increases Adjusted EBITDA Estimate

PR Newswire

ENGLEWOOD, Colo., Jan. 12, 2021 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced orders for Q4 2020.

Thomas Sandgaard, CEO of Zynex said: “We concluded 2020 with strong orders and posted 117% year over year growth. For the full year orders grew 96% which in the midst of a pandemic is a very solid result. Our sales team continues to do a great job as they deal with unforeseen challenges brought about by COVID-19.

During Q4, we continued to aggressively hire sales reps as we exceeded 500 sales reps at year-end. We expect to have approximately 600 sales reps in the U.S. by the end of 2021.

The Company is confirming its previous revenue estimate for the fourth quarter of 2020 of between $25.5 and $26.5 million and is increasing its fourth quarter Adjusted EBITDA estimate to between $3.1 and $4.1 million. The previous estimate was between $2.3 and $3.3 million.

The Company’s full year 2020 revenue estimate is between $80 and $81 million. The revenue estimate is approximately 76% to 78% above last year’s full year revenue of $45.5 million.

2020 full year estimated Adjusted EBITDA is estimated between $13.3 to $14.3 million which is 10% to 18% above 2019’s full year Adjusted EBITDA of $12.1 million.

Our prescription-strength NexWave device is a healthy alternative to prescribing opioids as the first line of defense when treating pain. We continue to add additional sales reps in territories throughout the U.S. that we have not covered previously.

We continue to advocate for pain patients, and for physicians to prescribe our NexWave technology as the first line of defense in treating chronic and acute pain without side effects. We are dedicated to promoting our technology in an effort to remove patient addiction and other side effects from prescription opioids.”

About Zynex 

Zynex, founded in 1996, markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation; and the Company’s proprietary NeuroMove device designed to help recovery of stroke and spinal cord injury patients. Zynex is also developing a new blood volume monitor for use in hospitals and surgery centers.  For additional information, please visit: Zynex.com.

Safe Harbor Statement

This release contains forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995.

Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, forecasts, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore you should not rely on any of these forward looking statements.  The Company makes no express or implied representation or warranty as to the completeness of forward looking statements or, in the case of projections, as to their attainability or the accuracy and completeness of the assumptions from which they are derived. Factors that could cause actual results to materially differ from forward-looking statements include, but are not limited to, the need to obtain CE marking of new products, the acceptance of new products as well as existing products by doctors and hospitals, larger competitors with greater financial resources, the need to keep pace with technological changes, our dependence on the reimbursement for our products from health insurance companies, our dependence on third party manufacturers to produce our goods on time and to our specifications, implementation of our sales strategy including a strong direct sales force, the impact of COVID-19 on the global economy and other risks described in our filings with the Securities and Exchange Commission, including but not limited to our Annual Report on Form 10-K for the year ended December 31, 2019 as well as our quarterly reports on Form 10-Q and current reports on Form 8-K.

Any forward-looking statement made by us in this release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Contact:
Zynex, Inc.
(800) 495-6670

Investor Relations Contact:
Amato and Partners, LLC
Investor Relations Counsel
[email protected]

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/zynex-announces-117-year-over-year-order-growth-and-increases-adjusted-ebitda-estimate-301206351.html

SOURCE Zynex

Posted on

Berger Montague Investigates Alleged Securities Fraud Claims Against CD Projekt S.A. (OTC: OTGLY, OTGLF); Lead Plaintiff Deadline is February 22, 2021

PR Newswire

PHILADELPHIA, Jan. 12, 2021 /PRNewswire/ — Berger Montague is investigating potential securities fraud claims against CD Projekt S.A. (“CD Projekt” or the “Company”) on behalf of investors who purchased CD Projekt securities (OTC: OTGLY, OTGLF) between January 16, 2020 and December 17, 2020 (the “Class Period”).

If you purchased CD Projekt securities during the Class Period, have questions concerning your rights or interests, or would like to discuss Berger Montague’s investigation, please contact attorneys Andrew Abramowitz at [email protected] or (215) 875-3015, or Donnell Much at [email protected] or (215) 875-4667, or contact us at www.bergermontague.com/cd-projekt.

A recently filed lawsuit accuses the Company of misleading investors about the fact that its highly anticipated videogame, Cyberpunk 2077, was virtually unplayable on th e current-generation Xbox or PlayStation systems due to an overwhelming number of bugs, and thus it was reasonably foreseeable that Sony would remove Cyberpunk 2077 from the PlayStation store, and vendors would be forced to offer full refunds for the game.

On January 16, 2020, CD Projekt announced a five-month delay in the launch of Cyberpunk 2077, from April 2020 to September 2020, and represented that the “game is complete and playable.” After subsequent delays, the game was finally released on December 10, 2020, and immediately, players reported a host of bugs and issues that rendered the game unplayable.

On December 18, 2020, Bloomberg reported that Sony had announced it was pulling Cyberpunk 2077 from its PlayStation store and was offering full refunds to players. In a Twitter post the same day, the Company advised that “following [its] discussion with PlayStation, a decision was made to temporarily suspend digital distribution” of the game. Market Insider also quoted the Company’s CEO Adam Kicinski as stating during an analyst call that, “[a]fter three delays, we were too focused on releasing the game,” and “[w]e ignored signals about the need for additional time to refine the game on the base last-gen consoles.”

Following this news, the price of CD Projekt’s American Depository Receipts (ADRs) price fell precipitously, with OTGLY declining $3.44 per ADR (16%) to close at $18.50, and OTGLF declining $9.20 per ADR (10%) to close at $78.80 on December 18, 2020.

If you purchased CD Projekt securities, including ADRs, during the Class Period, you may seek Court appointment as lead plaintiff to represent other injured investors in a class action. The lead plaintiff appointment deadline is February 22, 2021. You do not need to be a lead plaintiff to share in any potential Class recovery.

Whistleblowers: Persons with non-public information regarding CD Projekt are encouraged to confidentially assist Berger Montague’s investigation or take advantage of the SEC Whistleblower program. Under this program, whistleblowers who provide original information may receive rewards totaling up to thirty percent (30%) of recoveries obtained by the SEC. For more information, contact us.


Berger Montague
, with offices in Philadelphia, Minneapolis, Washington, D.C., and San Diego, has been a pioneer in securities class action litigation since its founding in 1970. Berger Montague has represented individual and institutional investors for five decades and serves as lead counsel in courts throughout the United States.

Contacts:
Andrew Abramowitz, Senior Counsel
Berger Montague
(215) 875-3015
[email protected]  

Donnell Much, Associate
Berger Montague
(215) 875-4667
[email protected]

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/berger-montague-investigates-alleged-securities-fraud-claims-against-cd-projekt-sa-otc-otgly-otglf-lead-plaintiff-deadline-is-february-22-2021-301206039.html

SOURCE Berger Montague

Posted on

Qualys to Report Fourth Quarter and Full Year 2020 Financial Results on February 10

PR Newswire

FOSTER CITY, Calif., Jan. 12, 2021 /PRNewswire/ — Qualys, Inc. (NASDAQ: QLYS), a pioneer and leading provider of cloud-based IT, security and compliance solutions, today announced that the company will report its financial results for the fourth quarter and full year 2020 after the market closes on Wednesday, February 10, 2021.

Qualys will host a conference call and live webcast to discuss its fourth quarter and full year 2020 financial results at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) on Wednesday, February 10, 2021. To access the conference call, dial (877) 881-2609 in the U.S. or (970) 315-0463 for international participants with conference ID #1674355. A live webcast of the earnings conference call, investor presentation, and prepared remarks can be accessed at https://investor.qualys.com/events-presentations. A replay of the conference call will be available through the same webcast link following the end of the call.

About Qualys
Qualys, Inc. (NASDAQ: QLYS) is a pioneer and leading provider of cloud-based security and compliance solutions with over 15,700 active customers in more than 130 countries, including a majority of each of the Forbes Global 100 and Fortune 100. Qualys helps organizations streamline and consolidate their security and compliance solutions in a single platform and build security into digital transformation initiatives for greater agility, better business outcomes, and substantial cost savings.

The Qualys Cloud Platform and its integrated Cloud Apps deliver businesses critical security intelligence continuously, enabling them to automate the full spectrum of auditing, compliance, and protection for IT systems and web applications across on premises, endpoints, cloud, containers, and mobile environments. Founded in 1999 as one of the first SaaS security companies, Qualys has established strategic partnerships with leading cloud providers like Amazon Web Services, Microsoft Azure and the Google Cloud Platform, and managed service providers and consulting organizations including Accenture, BT, Cognizant Technology Solutions, Deutsche Telekom, DXC Technology, Fujitsu, HCL Technologies, IBM, Infosys, NTT, Optiv, SecureWorks, Tata Communications, Verizon and Wipro. The company is also a founding member of the Cloud Security Alliance. For more information, please visit www.qualys.com.  

Qualys and the Qualys logo are proprietary trademarks of Qualys, Inc. All other products or names may be trademarks of their respective companies.
 

Investor Contact

Vinayak Rao

Vice President, Corporate Development and Investor Relations
(650) 801-6210
[email protected]

 

Cision View original content:http://www.prnewswire.com/news-releases/qualys-to-report-fourth-quarter-and-full-year-2020-financial-results-on-february-10-301206165.html

SOURCE Qualys, Inc.

Posted on

Berkeley Lights Launches Opto Plasma B Discovery 4.0 to Accelerate Therapeutic Antibody Discovery Against Difficult Targets

EMERYVILLE, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) — Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the Opto™ Plasma B Discovery 4.0 workflow. Opto Plasma B Discovery 4.0 is the industry’s premier antibody discovery workflow by advancing from B cells to lead molecules in just 1 week.

This workflow enables our customers to:

  • Sample 4x more of the relevant biodiversity, screening up to 100,000 cells
  • Functionally test with highly sensitive cell-based assays
  • Recover not only sequences, but also re-expressed molecules without requiring costly gene synthesis and bacterial cloning
  • Increase the probability of success against hard-to-hit targets such as GPCRs and Ion Channels

By leveraging our proprietary OptoSeq™ Barcoded BCR, we enable rapid, accurate sequencing of paired heavy/light chain antibody genes by DNA fragmentation, NGS sequencing, and bioinformatics analysis. Additionally, Opto BCR Rapid Re-expression can be leveraged to rapidly re-express over one thousand antibodies in just one week to confirm their function in plate-based assays, reducing the cost and labor associated with gene synthesis and bacterial cloning.

“Our customers are facing great challenges today, trying to find therapeutics against very difficult targets such as GPCRs for cancer and neurological disorders, while working under extreme timeline pressure. Opto Plasma B Discovery 4.0 workflow is a game changer,” said Eric Hobbs, Ph.D., CEO of Berkeley Lights. “In 1 week from a sera positive mouse, our customers can now discover and advance lead molecules for hard-to-hit targets in one integrated workflow on the Berkeley Lights Beacon system. In addition to re-expressed molecules, we also provide sequences to our customers for further acceleration of these candidates to market by immediately initiating antibody engineering and cell line development efforts.”

About Berkeley Lights

Berkeley Lights is a leading Digital Cell Biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products for our customers. The Berkeley Lights Platform captures deep phenotypic, functional and genotypic information for thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. Our platform is a fully integrated, end-to-end solution, comprising proprietary consumables, including our OptoSelect™ chips and reagent kits, advanced automation systems, and application software. We developed the Berkeley Lights Platform to provide the most advanced environment for rapid functional characterization of single cells at scale, the goal of which is to establish an industry standard for our customers throughout their cell-based product value chain.

Berkeley Lights’ Beacon® and Lightning™ systems and Culture Station™ instrument are FOR RESEARCH USE ONLY. Not for use in diagnostic procedures.

Forward-Looking Statements

To the extent that statements contained in this press release are not descriptions of historical facts regarding Berkeley Lights or its products, they are forward-looking statements reflecting the current beliefs and expectations of management. Such forward-looking statements involve substantial known and unknown risks and uncertainties that relate to future events, and actual results and product performance could differ significantly from those expressed or implied by the forward-looking statements. Berkeley Lights undertakes no obligation to update or revise any forward-looking statements. For a further description of the risks and uncertainties relating to the Company’s products, including the performance of Company workflows such as the Opto Plasma B Discovery 4.0 workflow, see the statements in the “Risk Factors” sections, and elsewhere, in our filings with the U.S. Securities and Exchange Commission.

Press Contact

[email protected]

Investor Contact

[email protected]



Posted on

Teradyne and Syntiant Collaborate to Significantly Shorten Time to Market for Innovative Artificial Intelligence Neural Decision Processors

NORTH READING, Mass., Jan. 12, 2021 (GLOBE NEWSWIRE) — Teradyne, Inc. (NASDAQ:TER), a leading supplier of automated test solutions, today announced that the company’s UltraFLEX test platform has enabled AI chip company SyntiantCorp. to successfully ship millions of its microwatt-power, deep learning Neural Decision Processors™ to customers worldwide.

Built from a clean sheet, hardware/software co-design methodology that optimizes silicon and deep learning models together, the Syntiant® NDP100™ and Syntiant® NDP101™ Neural Decision Processors™ bring hands-free, cloud-free, always-on voice and sensor AI applications to battery-powered edge devices.

“Our deep learning NDP10x chips leverage our custom designed near-memory compute architecture, so we were looking for a partner with a deep understanding of the AI chip market. The UltraFLEX power supplies were critical for the low current measurements needed to characterize our device, and drive quality and yield in production,” said Pieter Vorenkamp, COO at Syntiant. “Teradyne’s testing methodology supported our aggressive go-to market strategy, enabling us to go from qualification to production in just eight short weeks. We look forward to working closely with Teradyne as we introduce our second generation products and significantly accerlate our volume ramp.”

Syntiant’s NDP10x chips run AI workloads under 140uW and improve efficiency by 100x and throughput by 10x compared to traditional MCUs. Syntiant’s architecture supports dozens of application-defined audio classifications, such as keyword spotting, wake word detection, speaker identification, audio event and environment classification, as well as sensor analytics.

“From startups to hyperscalers, Teradyne is committed to providing the lowest cost of test and collaborating with our customers as a consultative solution partner,” said Regan Mills, Vice President of Marketing at Teradyne. “For Syntiant, our Protocol Aware tester architecture, IG-XL software, and extensive applications expertise were key in accelerating the qualification process. We look forward to continuing to work with Syntiant in bringing their innovative AI Neural Decision Processors to market.”

Using its UltraFLEX test platform, Teryadne is currently supporting the qualification and production ramp of the Syntiant® NDP120™ and Syntiant® NDP121™ Neural Decision Processors, Syntiant Corp’s second generation hardware platform to run multiple audio applications simultaneously at under 1mW power consumption.

For more information about Teradyne’s AI offerings, visit: https://www.teradyne.com/ai

About Teradyne

Teradyne (NASDAQ:TER) brings high-quality innovations such as smart devices, life-saving medical equipment and data storage systems to market, faster. Its advanced test solutions for semiconductors, electronic systems, wireless devices and more ensure that products perform as they were designed. Its Industrial Automation offerings include collaborative and mobile robots that help manufacturers of all sizes improve productivity and lower costs. In 2019, Teradyne had revenue of $2.3 billion and today employs 5,500 people worldwide. For more information, visit teradyne.com. Teradyne® is a registered trademark of Teradyne, Inc. in the U.S. and other countries.

About Syntiant

Founded in 2017 and headquartered in Irvine, Calif., Syntiant Corp. is moving artificial intelligence and machine learning from the cloud to edge devices. Syntiant’s advanced chip solutions merge deep learning with semiconductor design to produce ultra-low-power, high performance, deep neural network processors for always-on applications in battery-powered devices, such as smartphones, smart speakers, earbuds, hearing aids and laptops. The company is backed by several of the world’s leading strategic and financial investors, including Intel Capital, Microsoft’s M12, Applied Ventures, Robert Bosch Venture Capital, the Amazon Alexa Fund and Atlantic Bridge Capital. Syntiant continues to be recognized as an industry leader, being named to Gartner’s April 2020 Cool Vendors in AI Semiconductors; Fast Company’s prestigious list of the World’s Most Innovative Companies for 2020; and as a CES® 2020 and CES® 2021 Best of Innovation Awards Honoree; among others. More information on the company can be found by visiting www.syntiant.com or by following Syntiant on Twitter @Syntiantcorp.

For more information, contact:

Andrew Blanchard
Investor Relations, Teradyne
978.370.2425
[email protected]



Posted on

Yes& Significantly Expands Government Business with Three Key Contract Wins

Agency to Provide Strategic Marketing Communications Services to FEMA, USDA, and DOT

Alexandria, VA, Jan. 12, 2021 (GLOBE NEWSWIRE) — Yes& today announced a significant expansion of its government business through the award of three key contracts. After a thorough and focused business development effort, the company was selected to provide a variety of strategic marketing communications services to the Federal Emergency Management Agency (FEMA), U.S. Department of Agriculture (USDA), and U.S. Department of Transportation (DOT).

“Sometimes in adversity there is opportunity,” said Robert W. Sprague, President & CEO, Yes&. “We have used the COVID-19 pandemic as an opportunity to double down on business development activity in the still-strong public sector, looking for ways to serve our current clients even better, and to pursue new opportunities on the basis of our success in meeting the needs of government agencies and business-to-government clients.”

Over the past few months, Yes& has been awarded the following government contracts:

FEMA National Flood Insurance Program (NFIP)

Yes& will provide strategic marketing, communications, public relations, and advertising services to support NFIP’s goals of enhancing flood risk awareness, increasing flood insurance sales, driving current policyholders’ understanding of their policy, and encouraging mitigation behavior through the NFIP. The five-year Blanket Purchase Agreement (BPA) has a ceiling of $112 million.

USDA Food and Nutrition Services (FNS)

Yes& is supporting the Child Nutrition Programs (CNP) through content development, design, and Section 508 compliance services for new and existing CNP and other FNS program materials. This includes updating the design for Grow It, Try It, Like It! Fun with Fruits and Vegetables at Family Child Care – a resource that provides child care providers with information on teaching preschoolers about fruits and vegetables. Yes& will also standardize, design, and provide Section 508 remediation of the Child and Adult Care Food Program (CACFP) Multicultural Child Care Recipes. This five-year Blanket Purchase Agreement (BPA) has a ceiling of $15 million.

DOT Federal Motor Carrier Safety Administration (FMCSA)

Yes& was awarded the largest two Call Orders under the first option year of a five-year BPA with FMCSA. The agency’s continuing work includes marketing, communications and advertising services that aim to educate and advocate for the reduction of crashes, injuries and fatalities that involve large trucks and buses. The Call Orders cover communications campaigns and strategic services that build awareness and engagement with industry, safety advocates and state/local governments to keep our nation’s roadways safe and improve Commercial Motor Vehicle safety. The agency is also producing communications campaigns and providing strategic services to promote the national safety campaign “Our Roads, Our Safety,” which teaches about sharing the road safely with large trucks and buses.

 

About Yes&

Yes& is the Washington, DC-based marketing agency that brings commercial, association, and government clients the unlimited power of “&” – using a full suite of branding, digital, event, marketing, public relations, and creative capabilities to deliver meaningful and measurable results. Learn more at www.yesandagency.com

 

###



A.J. Guenther
Yes&
7038231600
[email protected]

Posted on

Leading Celebrity Trainer Launches SCULPT, New Fitness App Now Available to Stream to Your Smart TV

The fitness app was formulated by OC-based personal trainer, Ken Rawlins, and features quick workouts that target specific body parts to effectively shape and tone the perfect physique

NEWPORT BEACH, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) — Certified personal trainer, nutritionist and body transformation specialist, Ken Rawlins, today announces the smart TV connectivity option for SCULPT – a new innovative fitness app developed for home and gym training. This feature gives customers the option to view exercises (with extreme clarity) on a larger screen alongside the upbeat and inspiring music programmed for each workout.

SCULPT features a nutritional guide and innovative virtual training techniques proven to keep users motivated through evolving exercises and engaging regimens – perfect for anyone looking to tighten, tone and enhance curves without bulking or bloating.

As one of Orange County’s top trainers, Rawlins regularly works with superstar celebrities, professional athletes, and popular social media influencers to get them looking and feeling their best. After a traumatic car accident at the beginning of 2020 left Rawlins with a broken back, broken bones, a lung contusion and several other life-threatening injuries, he used his temporary setback to begin revolutionizing the fitness industry and put his experience and passion to work by launching SCULPT.

“At one point there was so much demand that I didn’t have enough hours in the day to train my clients in-person at Ken Rawlins Fitness,” said Rawlins. “I created SCULPT so that I could reach as many people as possible without sacrificing one-on-one quality instruction. My goal is to help people train anytime, anywhere and through this platform I’m able to continue helping transform both mental and physical wellness.”

For $19.99 a month, users will have access from the comfort of their homes to simple, creative and engaging workouts designed to accommodate all levels of fitness, from beginner to advanced. SCULPT’s diverse and engaging cardio and resistance exercise programs work to improve strength and stamina while boosting confidence every step of the way. The average workout is less than 10 minutes and is designed to be brief to accommodate any busy schedule and focuses on toning a specific muscle group. This “push and play” workout model allows users to mix and match fitness programs and keep their routines simple and effective. SCULPT also includes easy to follow meal plans, supplement suggestions and nutrition tips and tricks at no additional cost.

SCULPT is now available in both the App Store and Google Play. The fitness app is always evolving, and users can expect updates in the months to come including visual demonstrations with descriptive captions and stretching programs to help individuals improve mobility.

ABOUT Ken Rawlins Fitness:

Ken Rawlins is an IFBB Pro, sponsored athlete, personal trainer, nutrition consultant, online fitness coach, entrepreneur and a disciplined visionary who is committed to motivation through fitness and exercise. Rawlins’ creativity, drive and commitment are what fuels his fire to be the best fitness professional in Orange County. As an exercise product developer from Newport Beach, CA., Ken holds nine patents on seven innovative exercise products with a goal to solve problems with market driven solutions. Currently, Rawlins is an independent contractor at All 4 Health N Wellness in Newport Beach, Calif. Rawlins launched SCULPT in November 2020. For more, visit Rawlins’ website at http://www.kenrawlins.com/ or follow him on Facebook, Instagram and Twitter.

Media Contact:

Abigail Lacaillade
Uproar PR for SCULPT
(407) 547-9700
[email protected]